PMID- 21377143 OWN - NLM STAT- MEDLINE DCOM- 20111129 LR - 20161125 IS - 1879-1506 (Electronic) IS - 0003-9969 (Linking) VI - 56 IP - 9 DP - 2011 Sep TI - Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells. PG - 924-31 LID - 10.1016/j.archoralbio.2011.02.002 [doi] AB - OBJECTIVE: To study the effects of minocycline hydrochloride (MINO) on the formation of tartrate-resistant acid phosphatase (TRAP) staining-positive multinucleated osteoclast-like cells in mouse bone marrow cells (BMCs) treated with 1alpha,25(OH)(2)D(3) or soluble receptor activator of nuclear factor-kappaB ligand (s-RANKL). MATERIALS AND METHODS: Mouse BMCs were cultured in alpha-modified minimum essential medium containing foetal calf serum (10%) and tetracyclines (2.5, 5 and 10muM), such as MINO, tetracycline hydrochloride (TC), oxytetracycline hydrochloride (OXT) or doxycycline (DOXY) in the presence of 1alpha,25(OH)(2)D(3) (10nM) or s-RANKL (20ng/ml) for 7 days, and the number of TRAP staining-positive osteoclast-like cells was counted. In RNA isolated from BMCs treated with 1alpha,25(OH)(2)D(3) or s-RANKL in the presence or absence of MINO, the expressions of osteoclast differentiation relating to mRNA were analysed by reverse transcription-polymerase chain reaction. Cell viability was examined in mouse BMCs and rabbit osteoclasts treated with MINO (0.25-20muM and 2-50muM, respectively) for 24h. RESULTS: MINO, TC, OXT or DOXY inhibited 1alpha,25(OH)(2)D(3)-induced osteoclast-like cell formation in mouse BMCs dose dependently. MINO suppressed 1alpha,25(OH)(2)D(3)-induced up-regulation of mRNA expressions of TRAP, cathepsin K, carbonic anhydrase II, and calcitonin receptor, but not RANKL. MINO inhibited s-RANKL-induced osteoclast-like cell formation and up-regulation of mRNA expressions for nuclear factor of activated T-cells c1 (NFATc1), a key regulator of osteoclast differentiation; however, MINO had no effects on the viability of mouse BMCs and rabbit osteoclasts. CONCLUSION: MINO inhibits RANKL-induced osteoclastogenesis via down-regulation of NFATc1 mRNA expression in osteoclast precursor cells. CI - Copyright (c) 2011 Elsevier Ltd. All rights reserved. FAU - Nagasawa, Tsuneyasu AU - Nagasawa T AD - Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan. FAU - Arai, Michitsugu AU - Arai M FAU - Togari, Akifumi AU - Togari A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110305 PL - England TA - Arch Oral Biol JT - Archives of oral biology JID - 0116711 RN - 0 (Anti-Bacterial Agents) RN - 0 (Isoenzymes) RN - 0 (NFATC Transcription Factors) RN - 0 (RANK Ligand) RN - EC 3.1.3.2 (Acid Phosphatase) RN - EC 3.1.3.2 (Acp5 protein, mouse) RN - EC 3.1.3.2 (Tartrate-Resistant Acid Phosphatase) RN - FXC9231JVH (Calcitriol) RN - FYY3R43WGO (Minocycline) SB - IM MH - Acid Phosphatase/metabolism MH - Animals MH - Anti-Bacterial Agents/*pharmacology MH - Bone Marrow Cells/cytology/*drug effects MH - Calcitriol/pharmacology MH - Cell Differentiation/drug effects MH - Cell Survival/drug effects MH - Cells, Cultured MH - Down-Regulation MH - Isoenzymes/metabolism MH - Male MH - Mice MH - Mice, Inbred Strains MH - Minocycline/*pharmacology MH - NFATC Transcription Factors/*biosynthesis MH - Osteoclasts/cytology/*drug effects MH - RANK Ligand/pharmacology MH - Rabbits MH - Tartrate-Resistant Acid Phosphatase EDAT- 2011/03/08 06:00 MHDA- 2011/12/13 00:00 CRDT- 2011/03/08 06:00 PHST- 2010/11/11 00:00 [received] PHST- 2011/01/06 00:00 [revised] PHST- 2011/02/02 00:00 [accepted] PHST- 2011/03/08 06:00 [entrez] PHST- 2011/03/08 06:00 [pubmed] PHST- 2011/12/13 00:00 [medline] AID - S0003-9969(11)00034-3 [pii] AID - 10.1016/j.archoralbio.2011.02.002 [doi] PST - ppublish SO - Arch Oral Biol. 2011 Sep;56(9):924-31. doi: 10.1016/j.archoralbio.2011.02.002. Epub 2011 Mar 5.